FR Alpha Peptide Vaccine
/ National Cancer Institute
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
September 26, 2022
Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer
(clinicaltrials.gov)
- P2 | N=280 | Active, not recruiting | Sponsor: Academic and Community Cancer Research United | Trial primary completion date: Jul 2023 ➔ Aug 2022
Trial primary completion date • Breast Cancer • HER2 Breast Cancer • Hormone Receptor Breast Cancer • Oncology • Solid Tumor • Triple Negative Breast Cancer • ER • HER-2 • PGR
September 06, 2022
Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer
(clinicaltrials.gov)
- P2 | N=280 | Active, not recruiting | Sponsor: Academic and Community Cancer Research United | Recruiting ➔ Active, not recruiting
Enrollment closed • Breast Cancer • HER2 Breast Cancer • Hormone Receptor Breast Cancer • Oncology • Solid Tumor • Triple Negative Breast Cancer • ER • HER-2 • PGR
1 to 2
Of
2
Go to page
1